Pro Medicus Limited (ASX:PME)
Australia · Delayed Price · Currency is AUD 223.72
-2.33 (-1.03%)
Dec 17, 2025, 11:19 AM AEST
Pro Medicus Market Cap
Pro Medicus has a market cap or net worth of 23.62 billion as of December 16, 2025. Its market cap has decreased by -13.48% in one year.
Market Cap
23.62B
Enterprise Value
23.41B
Revenue
212.98M
Ranking
n/a
PE Ratio
205.31
Stock Price
223.72
Market Cap Chart
Since October 10, 2000, Pro Medicus's market cap has increased from 142.00M to 23.62B, an increase of 16,532.74%. That is a compound annual growth rate of 22.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 16, 2025 | 23.62B | -9.64% |
| Dec 31, 2024 | 26.14B | 161.11% |
| Dec 29, 2023 | 10.01B | 73.45% |
| Dec 30, 2022 | 5.77B | -11.46% |
| Dec 31, 2021 | 6.52B | 83.09% |
| Dec 31, 2020 | 3.56B | 53.23% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.73B |
| Cochlear | 17.23B |
| Sonic Healthcare | 11.46B |
| Ramsay Health Care | 8.16B |
| Ansell | 5.12B |
| Telix Pharmaceuticals | 4.65B |
| Mesoblast | 3.55B |
| Neuren Pharmaceuticals | 2.41B |